CNClaus U. Niemann

Claus U. Niemann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Claus U. Niemann has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Darren Malinoski

    Division of Trauma, Critical Care, and Acute Care Surgery, Oregon Health & Science University, Portland

    4 shared publications
  • Kristine Broglio

    Oncology Statistical Innovation, AstraZeneca, Gaithersburg, Maryland

    4 shared publications
  • John Feiner

    University of California, San Francisco (AO, JF, RH, JPR, CUN), California Transplant Donor Network, Oakland, California (SS), Hospital Clinic, Barcelona, Spain (AB)

    2 shared publications
  • John P. Roberts

    University of California, San Francisco (AO, JF, RH, JPR, CUN), California Transplant Donor Network, Oakland, California (SS), Hospital Clinic, Barcelona, Spain (AB)

    2 shared publications
  • Ryutaro Hirose

    University of California, San Francisco (AO, JF, RH, JPR, CUN), California Transplant Donor Network, Oakland, California (SS), Hospital Clinic, Barcelona, Spain (AB)

    2 shared publications
  • Sharon Swain

    University of California, San Francisco (AO, JF, RH, JPR, CUN), California Transplant Donor Network, Oakland, California (SS), Hospital Clinic, Barcelona, Spain (AB)

    2 shared publications

Latest Publications

  • Open Access

    Therapeutic Hypothermia in Low-Risk Nonpumped Brain-Dead Kidney Donors

    by Madhukar S. Patel, Juan D. Salcedo-Betancourt, Christina Saunders, Kristine Broglio, Darren Malinoski, Claus U. Niemann

    Importance: Delayed graft function in kidney-transplant recipients is associated with increased financial cost and patient burden. In donors with high Kidney Donor Profile Index whose kidneys are not pumped, therapeutic hypothermia has been shown to confer a protective benefit against delayed graft function.Objective: To determine whether hypothermia is superior to normothermia in preventing delayed graft function in low-risk nonpumped kidney donors after brain death.Design, Setting, and Participants: In a multicenter randomized clinical trial, brain-dead kidney donors deemed to be low risk and not requiring machine perfusion per Organ Procurement Organization protocol were prospectively randomized to hypothermia (34.0-35 °C) or normothermia (36.5-37.5 °C) between August 10, 2017, and May 21, 2020, across 4 Organ Procurement Organizations in the US (Arizona, Upper Midwest, Pacific Northwest, and Texas). The final analysis report is dated June 15, 2022, based on the data set received from the United Network for Organ Sharing on June 2, 2021. A total of 509 donors (normothermia: n = 245 and hypothermia: n = 236; 1017 kidneys) met inclusion criteria over the study period.Intervention: Donor hypothermia (34.0-35.0 °C) or normothermia (36.5-37.5 °C).Main Outcomes and Measures: The primary outcome was delayed graft function in the kidney recipients, defined as the need for dialysis within the first week following kidney transplant. The primary analysis follows the intent-to-treat principle.Results: A total of 934 kidneys were transplanted from 481 donors, of which 474 were randomized to the normothermia group and 460 to the hypothermia group. Donor characteristics were similar between the groups, with overall mean (SD) donor age 34.2 (11.1) years, and the mean donor creatinine level at enrollment of 1.03 (0.53) mg/dL. There was a predominance of Standard Criteria Donors (98% in each treatment arm) with similar low mean (SD) Kidney Donor Profile Index (normothermia: 28.99 [20.46] vs hypothermia: 28.32 [21.9]). Cold ischemia time was similar in the normothermia and hypothermia groups (15.99 [7.9] vs 15.45 [7.63] hours). Delayed graft function developed in 87 of the recipients (18%) in the normothermia group vs 79 (17%) in the hypothermia group (adjusted odds ratio, 0.92; 95% CI, 0.64-1.33; P = .66).Conclusions and Relevance: The findings of this study suggest that, in low-risk non-pumped kidneys from brain-dead kidney donors, therapeutic hypothermia compared with normothermia does not appear to prevent delayed graft function in kidney transplant recipients.Trial Registration: ClinicalTrials.gov Identifier: NCT02525510


  • Therapeutic Hypothermia in Organ Donors: Follow-up and Safety Analysis

    by Darren Malinoski, Madhukar S. MD Patel, David A. Md Axelrod, Kristine Broglio, Roger J. Lewis, Tahnee Groat, Claus U. Niemann

    Background.: In a recent trial, targeted mild hypothermia in brain-dead organ donors significantly reduced the incidence of delayed graft function after kidney transplantation. This trial was stopped early for efficacy. Here, we report long-term graft survival for all organs along with donor critical care end points. Methods.: We assessed graft survival through 1 year of all solid organs transplanted from 370 donors who had been randomly assigned to hypothermia (34–35°C) or normothermia (36.5–37.5°C) before donation. Additionally, changes in standardized critical care end points were compared between donors in each group. Results.: Mild hypothermia was associated with a nonsignificant improvement in 1-year kidney transplant survival (95% versus 92%; hazard ratio, 0.61 [0.31–1.20]; P = 0.15). Mild hypothermia was associated with higher 1-year graft survival in the subgroup of standard criteria donors (97% versus 93%; hazard ratio, 0.39 [0.15 to −1.00]; P = 0.05). There were no significant differences in graft survival of extrarenal organs. There were no differences in critical care end points between groups. Conclusions.: Mild hypothermia in the donor safely reduced the rate of delayed graft function in kidney transplant recipients without adversely affecting donor physiology or extrarenal graft survival. Kidneys from standard criteria donors who received targeted mild hypothermia had improved 1-year graft survival.


  • State of the Science in Deceased Organ Donor Management

    by Madhukar S. Patel, Mitchell Sally, Claus U. Niemann, Darren J. Malinoski


  • Impact of a Quality Improvement Project on Deceased Organ Donor Management

    by Andrea Olmos, John Feiner, Ryutaro Hirose, Sharon Swain, Annabel Blasi, John P. Roberts, Claus U. Niemann

    Context—: Donors showed poor glucose control in the period between declaration of brain death and organ recovery. The level of hyperglycemia in the donors was associated with a decline in terminal renal function. Objective—: To determine whether implementation of a quality improvement project improved glucose control and preserved renal function in deceased organ donors. Methods—: Data collected retrospectively included demographics, medical history, mechanism of death, laboratory values, and data from the United Network for Organ Sharing. Results—: After implementation of the quality improvement project, deceased donors had significantly lower mean glucose concentrations (mean [SD], 162 [44] vs 212 [42] mg/dL; P < .001) and prerecovery glucose concentration (143 [66] vs 241 [69] mg/dL; P < .001). When the donor cohorts from before and after the quality improvement project were analyzed together, mean glucose concentration remained a significant predictor of terminal creatinine level ( P < .001). Multivariate analysis of delayed graft function in kidney recipients matched to donors indicated that higher terminal creatinine level was associated with delayed graft function in recipients ( P < .001). Conclusion—: The quality improvement project improved donor glucose homeostasis, and the data confirm that poor glucose homeostasis is associated with worsening terminal renal function.


  • Top Cited Papers
    Open Access

    Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function

    by Claus U. Niemann, John Feiner, Sharon Swain, Scott Bunting, Melissa Friedman, Megan Crutchfield, Kristine Broglio, Ryutaro Hirose, John P. Roberts, Darren Malinoski

    Delayed graft function, which is reported in up to 50% of kidney-transplant recipients, is associated with increased costs and diminished long-term graft function. The effect that targeted mild hypothermia in organ donors before organ recovery has on the rate of delayed graft function is unclear.


  • Abdominal Transplantation

    by Claus U. Niemann

  • Open Access

    Deceased Organ Donor Research: The Last Research Frontier?

    by Thomas Mone, John Heldens, Claus U. Niemann


  • Mild hypothermia reduces the inflammatory response and hepatic ischemia/reperfusion injury in rats

    by Matthias Behrends, Ryutaro Hirose, Natalie J. Serkova, John L. Coatney, Melanie Bedolli, Jason Yardi, Yeon Ho Park, Claus U. Niemann

    Hypothermia is known to protect against ischemia/reperfusion (I/R) injury. The mechanisms of protection are incompletely understood and a temperature threshold for protection has not been established. In anesthetized Wistar rats, partial (70%) hepatic ischemia was applied for 45 min. Three study groups were used. Group T31 (n = 6) spontaneously cooled to 31.3 +/- 0.8 degrees C, while group T34 (n = 6) spontaneously cooled to 34 degrees C and was then maintained at 34.0 +/- 0.1 degrees C using a heat lamp. The normothermic group (T37, n = 6) was maintained at 37.1 +/- 0.3 degrees C. Hepatic injury, inflammation, lipid peroxidation and metabolic function (using quantitative 1H-NMR) were assessed 24 h after reperfusion. At 24 h following reperfusion, alanine aminotransferase and aspartate aminotransferase increased to 5101 +/- 2378 and 6409 +/- 4202 U/l in the normothermic T37 group (P < 0.05 vs. T34 and T31), whereas transaminases in hypothermic groups (T31 and T34) were significantly lower. Severe liver necrosis was only noted with T37. Myeloperoxidase activity was increased in the T37 group when compared with hypothermic groups (223 +/- 161 (T37) vs. 16 +/- 10 (T31) and 8 +/- 5 (T34) mU/min/mg of tissue, P<0.05 vs. T31 and T34). 1H-NMR analysis of the blood of normothermic animals revealed metabolic changes consistent with increased ischemic injury, which was almost completely ameliorated in T34 and T31 groups. Mild hypothermia of 34 degrees C is sufficient to reduce I/R injury by inhibiting the inflammatory response. Further spontaneous cooling to 31 degrees C did not demonstrate any additional protective effect.